Inhibitors of the renin-angiotensin-aldosterone system and COVID-19 in critically ill elderly patients.
作者信息
Jung Christian, Bruno Raphael Romano, Wernly Bernhard, Joannidis Michael, Oeyen Sandra, Zafeiridis Tilemachos, Marsh Brian, Andersen Finn H, Moreno Rui, Fernandes Ana Margarida, Artigas Antonio, Pinto Bernardo Bollen, Schefold Joerg, Wolff Georg, Kelm Malte, De Lange Dylan W, Guidet Bertrand, Flaatten Hans, Fjølner Jesper
机构信息
Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University Duesseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany.
Department of Cardiology, Paracelsus Medical University, Müllner Hauptstraße 48, A-5020 Salzburg, Austria.
出版信息
Eur Heart J Cardiovasc Pharmacother. 2021 Jan 16;7(1):76-77. doi: 10.1093/ehjcvp/pvaa083.
Abstract
摘要
相似文献
1
Inhibitors of the renin-angiotensin-aldosterone system and COVID-19 in critically ill elderly patients.肾素-血管紧张素-醛固酮系统抑制剂与危重症老年患者的新型冠状病毒肺炎
Eur Heart J Cardiovasc Pharmacother. 2021 Jan 16;7(1):76-77. doi: 10.1093/ehjcvp/pvaa083.
2
COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved?新型冠状病毒肺炎、高血压与肾素-血管紧张素-醛固酮系统抑制剂：小题大做还是亟待解决的实际问题？
J Clin Hypertens (Greenwich). 2020 Nov;22(11):1984-1986. doi: 10.1111/jch.14045. Epub 2020 Sep 20.
3
Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.肾素-血管紧张素-醛固酮系统抑制剂与新型冠状病毒肺炎患者的预后：一项病例系列研究。
Hypertension. 2020 Aug;76(2):e10-e12. doi: 10.1161/HYPERTENSIONAHA.120.15312. Epub 2020 May 8.
4
COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial.2019冠状病毒病、高血压与肾素-血管紧张素-醛固酮系统阻滞剂：BRACE-CORONA试验
Cardiovasc Res. 2020 Dec 1;116(14):e198-e199. doi: 10.1093/cvr/cvaa325.
5
Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome.COVID-19 综合征住院后血管紧张素转换酶抑制剂或血管紧张素 II 受体拮抗剂的预先给药与生存。
J Am Heart Assoc. 2020 Nov 17;9(22):e017364. doi: 10.1161/JAHA.120.017364. Epub 2020 Oct 7.
6
Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.肾素-血管紧张素-醛固酮系统抑制剂治疗高血压患者可降低COVID-19死亡率：一项荟萃分析
Hypertension. 2020 Aug;76(2):e13-e14. doi: 10.1161/HYPERTENSIONAHA.120.15572. Epub 2020 May 27.
7
A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.中国 2 家中心回顾性研究：血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂在高血压合并 COVID-19 患者中的持续使用效果。
Med Sci Monit. 2020 Sep 24;26:e926651. doi: 10.12659/MSM.926651.
8
SARS-CoV-2 effects on the renin-angiotensin-aldosterone system, therapeutic implications.严重急性呼吸综合征冠状病毒2对肾素-血管紧张素-醛固酮系统的影响及治疗意义
Acta Physiol (Oxf). 2021 Apr;231(4):e13608. doi: 10.1111/apha.13608. Epub 2021 Jan 7.
9
COVID-19: The heart of the issue.新冠病毒：问题的核心。
J Card Surg. 2020 Aug;35(8):2112. doi: 10.1111/jocs.14684. Epub 2020 Jun 16.
10
Cardiovascular disease and the impact of COVID-19.心血管疾病与2019冠状病毒病的影响
J Card Surg. 2020 Aug;35(8):2113. doi: 10.1111/jocs.14682. Epub 2020 Jun 16.
引用本文的文献
1
COVID-19 machine learning model predicts outcomes in older patients from various European countries, between pandemic waves, and in a cohort of Asian, African, and American patients.新冠病毒机器学习模型可预测来自欧洲不同国家的老年患者在疫情不同波次间以及亚洲、非洲和美洲患者队列中的预后情况。
PLOS Digit Health. 2022 Nov 8;1(11):e0000136. doi: 10.1371/journal.pdig.0000136. eCollection 2022 Nov.
2
The association of prior paracetamol intake with outcome of very old intensive care patients with COVID-19: results from an international prospective multicentre trial.先前对扑热息痛的摄入与 COVID-19 极老年重症监护患者结局的关联：一项国际前瞻性多中心试验的结果。
BMC Geriatr. 2022 Dec 27;22(1):1000. doi: 10.1186/s12877-022-03709-w.
3
Drugs acting on the renin-angiotensin-aldosterone system (RAAS) and deaths of COVID-19 patients: a systematic review and meta-analysis of observational studies.作用于肾素-血管紧张素-醛固酮系统（RAAS）的药物与COVID-19患者死亡：观察性研究的系统评价和荟萃分析
Egypt Heart J. 2022 Sep 6;74(1):64. doi: 10.1186/s43044-022-00303-8.
4
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.研究2019冠状病毒病重症和死亡风险因素的研究中的异质性和偏倚风险：一项系统评价和荟萃分析
Pathogens. 2022 May 10;11(5):563. doi: 10.3390/pathogens11050563.
5
Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research.肾素-血管紧张素-醛固酮系统抑制剂与 COVID-19：系统评价和荟萃分析揭示了大量观察性研究中的关键偏倚。
J Am Heart Assoc. 2022 Jun 7;11(11):e025289. doi: 10.1161/JAHA.122.025289. Epub 2022 May 27.
6
Association of chronic heart failure with mortality in old intensive care patients suffering from Covid-19.慢性心力衰竭与 COVID-19 老年重症监护患者死亡率的关系。
ESC Heart Fail. 2022 Jun;9(3):1756-1765. doi: 10.1002/ehf2.13854. Epub 2022 Mar 10.
7
Disease-Course Adapting Machine Learning Prognostication Models in Elderly Patients Critically Ill With COVID-19: Multicenter Cohort Study With External Validation.适用于新冠肺炎危重症老年患者病程的机器学习预后模型：多中心队列研究及外部验证
JMIR Med Inform. 2022 Mar 31;10(3):e32949. doi: 10.2196/32949.
8
Association between tracheostomy timing and outcomes for older critically ill COVID-19 patients: prospective observational study in European intensive care units.COVID-19 老年危重症患者气管切开时机与结局的相关性：欧洲重症监护病房的前瞻性观察性研究。
Br J Anaesth. 2022 Mar;128(3):482-490. doi: 10.1016/j.bja.2021.11.027. Epub 2021 Nov 29.
9
On the footsteps of Hippocrates, Sanctorius and Harvey to better understand the influence of cold on the occurrence of COVID-19 in European countries in 2020.循着希波克拉底、桑克托留斯和哈维的脚步，更好地了解 2020 年欧洲国家寒冷天气对 COVID-19 发生的影响。
Biochimie. 2021 Dec;191:164-171. doi: 10.1016/j.biochi.2021.09.009. Epub 2021 Sep 20.
10
COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment - A narrative review.COVID-19 相关急性呼吸窘迫综合征（CARDS）：病理生理学和 ICU 治疗的现有知识 - 叙述性综述。
Best Pract Res Clin Anaesthesiol. 2021 Oct;35(3):351-368. doi: 10.1016/j.bpa.2020.12.011. Epub 2020 Dec 17.
Zotero 插件